Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
ConditionCervical Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-60
SponsorLin Yuan
About this trial
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.
Eligibility criteria
Qualifiers
Women aged 20-60
There is a definite pathological diagnosis of cervical cancer
Women aged 20-60
No tumors in the uterus or other parts of the body
Disqualifiers
There are other lesions in the uterus and uterine adnexa
Pregnant, lactating or menarche women
Women who are undergoing human papillomavirus (HPV) vaccination
Trial design
Treatments tested in this trial
- Detection of serum AUNIP expression
Treatment groups
300 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Lin Yuan
Lead sponsor
Qianfoshan Hospital
Sponsor institution
Source ClinicalTrials.gov